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SUMMARY
In rodents andhumans, the liver can efficiently restore
its mass after hepatectomy. This is largely attributed
to the proliferation and cell cycle re-entry of hepato-
cytes. On the other hand, bone marrow cells (BMCs)
migrate into the liver after resection. Here, we find
that a block of BMC recruitment into the liver severely
impairs its regeneration after the surgery. Mobilized
hematopoietic stem and progenitor cells (HSPCs) in
the resected liver can fuse with hepatocytes, and
the hybrids proliferate earlier than the hepatocytes.
Genetic ablation of the hybrids severely impairs
hepatocyte proliferation and liver mass regeneration.
Mathematical modeling reveals a key role of bone
marrow (BM)-derived hybrids to drive proliferation in
the regeneration process, and predicts regeneration
efficiency in experimentally non-testable conditions.
In conclusion, BM-derived hybrids are essential to
trigger efficient liver regeneration after hepatectomy.
INTRODUCTION
Mathematical modeling is a powerful tool to describe com-
plex biological processes, formalize interactions between com-
ponents, analyze temporal dynamics, and predict the effects
of perturbations (Kitano, 2002). Modeling has been used to
describe liver functions and dynamics in mammals under normal
and pathological conditions (Cook et al., 2015; Furchtgott et al.,
2009; Holzh€utter et al., 2012; Periwal et al., 2014).
The liver is the main detoxifying organ of the body, which can
be injured by ingested toxins and infections. In response to these
insults, hepatocytes can proliferate (Michalopoulos and DeFran-
ces, 1997), and regeneration of the liver has evolved as a pro-
tective mechanism (Taub, 2004). Indeed, the mammalian liver
displays a high regeneration potential (Fausto et al., 2006;Micha-
lopoulos and DeFrances, 1997; Taub, 2004), and this phenome-
non was described in rats a long time ago through the two-thirds
partial hepatectomy model (Higgins and Anderson, 1931).
After partial hepatectomy, the remaining lobes grow and liver
mass is restored in approximately 1 week in rodents (Duncan
et al., 2009). The regeneration mechanism is largely attributed
to the re-entry of the hepatocytes into the cell cycle and their pro-
liferation (Fausto et al., 2006; Michalopoulos, 2007), which peaks
48 hr after resection in mice (Miyaoka et al., 2012). Cooperative
signals induced by growth factors (such as hepatocyte, trans-
forming, and epidermal growth factors, insulin, and glucagons)
and cytokines (such as tumor necrosis factor and interleukin 6)
are thought to be responsible for hepatocyte re-entry into the
cell cycle, DNA replication, proliferation, and consequent liver
mass regeneration (Costa et al., 2003).
However, there are still many unresolved key aspects in
this process. The cell volume of hepatocytes enlarges (Gentric
et al., 2012;Miyaoka et al., 2012), and there is amassive increase
of hematopoietic stem cells (HSCs) in the peripheral blood and in
the liver itself (De Silvestro et al., 2004; Fujii et al., 2002; Lemoli
et al., 2006), whose role is not clear. In addition, there is some
diverging evidence indicating that bone marrow (BM)-derived
cells can either transdifferentiate in vivo in themouse liver (Alison
et al., 2000; Lagasse et al., 2000) or can fuse with hepatocytes in
fumarylacetoacetate hydrolase (Fah)-deficient mice (Vassilo-
poulos et al., 2003; Wang et al., 2003).
Here, using modeling and experimental approaches, we
prove a crucial role of bone marrow cells (BMCs) and of BM-he-
patocyte hybrids in the dynamics and efficiency of mouse liver
regeneration upon 30% and 70% partial hepatectomy. A math-
ematical model, fitted on experimental data, unveils the critical
role of BMC recruitment and hybrid formation in enhancing
proliferation and, ultimately, liver regeneration.
RESULTS
Mathematical Model Recapitulates the Dynamics of
Mouse Liver Regeneration after Hepatectomy
In earlier work, a mathematical model for white rat liver regener-
ation upon partial hepatectomy was proposed (Furchtgott et al.,
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2009), which incorporates the main phenomenology and un-
derlying signaling. Similarly, the mathematical formalism of our
delay differential equations (DDEs) captures the rate of change
in cell numbers, considering the three populations previously
suggested to contribute to liver regeneration (Fausto et al.,
2006): quiescent (Q), primed to replicate (P), and replicating (R)
cells (Figure 1A). Coupled to cellular equations (Figure S1A), mo-
lecular equations describe immediate-early genes, cytokines,
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Figure 1. Derivation of a Mathematical Model Accounting for BMC Recruitment in the Liver upon 70% Partial Hepatectomy
(A) Schematic representation of cellular equations of the mathematical model. Blue font highlights the modifications to the rat model in Furchtgott et al. (2009).
B, bone marrow cells; Q, P, and R, parameters as defined in the text and the Supplemental Experimental Procedures.
(B) Liver regeneration of wild-type mice treated or not treated with AMD3100, which was calculated as liver weight/body weight ratio at different days after PHx.
(C) Experimental scheme: recruitment of YFP+ cells into the liver of BMYFP mice was analyzed by FACS 24 hr after PHx.
(D) Percentage of recruited YFP+ cells with respect to living cells (mixed parenchymal and bone marrow cell fractions) 24 hr after PHx. See Supplemental
Experimental Procedures for details about cell purification.
(E and F) Simulations of the fitted model for liver mass regeneration (E) and proliferation (F) for wild-type mice (BMCXCR4fl/fl) using normalized data from Figures 2C
and S2D. Data are represented as mean ± SEM (n = 6, B and D). p > 0.1; **p < 0.01; ***p < 0.0001.
See also Figure S1 and Table S1.
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and growth factors that, activated upon liver resection, deter-
mine the transition among cell states (Figure S1B; Supplemental
Experimental Procedures). The premise of ourmodel is the focus
on regeneration dynamics rather than on cellular species. Thus,
we adapted the phenomenological parameters in the cellular
equations, whereas the molecular equations and the related pa-
rameters were kept as intact as possible (Table S1). Notably, the
same approach has been successfully used in adapting the rat
model (Furchtgott et al., 2009) to reproduce data from humans
(Periwal et al., 2014) because the biochemistry of liver regenera-
tion is probably similar in different mammals.
To adapt the rat model, we noticed that, while in the rat, hepa-
tocyte proliferation starts soon after hepatectomy (Furchtgott
et al., 2009), in mice, the proliferation is delayed and peaks at
48 hr (Miyaoka et al., 2012; Weglarz and Sandgren, 2000). As
expected, 24 hr upon 70% resection in wild-type mice, liver cells
did not proliferate (Figure S1C) (Shu et al., 2009). We evaluated
liver mass regeneration 7 days after resection (Figure 1B, no
AMD3100) because this is a standard time range to analyze
regeneration (Zhang et al., 2015). Interestingly, we observed a
small but significant (p < 0.0001 between post-hepatectomy
and day 1) increase in liver mass at day 1 (Figure 1B, day 1 no
AMD3100) before cycling cells appeared (Figure S1C). This
was likely due to the recruitment of hematopoietic cells in early
stages of regeneration (De Silvestro et al., 2004; Lemoli et al.,
2006). To confirm this hypothesis, we applied 70% liver resec-
tion to a group of transgenic mice expressing the yellow fluo-
rescent protein (YFP) from the Rosa26-LoxP-stop-LoxP-YFP
allele in the hematopoietic cells (BMYFP) (Figure 1C). We found
up to 30% of YFP+ cells in the liver, indicating a massive recruit-
ment of hematopoietic cells within 24 hr from surgery (Figures 1D
and S1D).
Next, to determine the identity of the recruited YFP+ cells,
we examined the expression of markers of mature circulating
blood cells or bone-marrow-derived progenitors. YFP+ cells
expressed HSPC (c-kit+/sca1+) and granulocyte monocyte
progenitor (GMP) (c-Kit+/Sca1/Cd34+/Cd16.32+) markers
(Figure S1E). In contrast, we excluded recruitment of cells from
the peripheral blood because lineage-positive cells, such as
B (B220+), T (Cd3+), and NK (CD49b+/CD3 and CD49b+/
CD3+) cells, and macrophages (CD11b+ and CD11b+/F4-80+)
did not increase into the resected liver after hepatectomy (Fig-
ure S1F), suggesting that recruited YFP+ cells include mostly
BMCs.
Therefore, we changed the rat model to account for both the
role that BMC mobilization can play in liver regeneration in a
mouse and the different timing of hepatocyte proliferation and
regeneration. We included an explicit term for BMC recruitment,
and added two time delays (t and q) between the Q and P states
and the P and R states (Figures 1A and S1A). We fitted the math-
ematical model to time-courses (7 day experiments) of wild-type
mice that underwent hepatectomy; the dynamics of transition
among the Q, P, and R states depend on BMC recruitment.
The fitting accurately matches experimental proliferation and
regeneration dynamics (Figures 1E and 1F).
BMCMobilization Is Crucial for Hepatocyte Proliferation
and Effective Regeneration
C-X-C motif chemokine receptor type 4 (CXCR4) and its ligand,
SDF-1/CXCL12 (stromal cell-derived factor 1/C-X-C motif che-
mokine 12), are essential for the mobilization and migration of
BMCs from the niche (Dalakas et al., 2005; Hatch et al., 2002;
Kollet et al., 2003). Thus, to investigate if the recruitment of
BMCs into the liver was critical for its regeneration, we analyzed
BMC recruitment after 70% resection in theCXCR4fl/fl/Vav-CRE/
R26Y model, which carries BMCs deleted for CXCR4 and ex-
pressing YFP (BMYFP/CXCR4/) (Figure 2A). Of note, CXCR4fl/fl-
VavCRE mice are normal and fertile and do not show apparent
phenotypic defects, which could be ascribed to a bone marrow
dysfunction. Indeed, it has been shown that Flt3-LSK cells in
CXCR4/ mice are in a normal number as compared to wild-
type mice and sustained long-term hematopoiesis (Nie et al.,
2008). Moreover, no major differences were found in the number
of HSPCs in the fetal liver of CXCR4/ E14.5 embryos as
compared to wild-type mice (Foudi et al., 2006).
As opposed to the BMYFP wild-type mice, we observed a
massive impairment of YFP+ BMC recruitment in BMYFP/CXCR4/
(Figures 2B and S2A). Importantly, liver regeneration in
BMCXCR4/ animals was severely compromised and, up to
30 days after resection, BMCXCR4/ mice could not entirely
restore their liver mass (Figure 2C). Moreover, the block of liver
mass regeneration was associated with an impairment of liver
cell proliferation; the mitotic index and Ki67+ cells measured in
liver sections were drastically reduced 3 days after hepatectomy
Figure 2. CXCR4 Deletion in the BM Affects Cell Proliferation and Liver Regeneration after 70% PHx
(A) Experimental scheme: recruitment of YFP+ cells into the liver of BMYFP and BMYFP/CXCR4/ mice was analyzed by FACS 24 hr after PHx.
(B) Percentage of recruited YFP+ cells, which was calculated with respect to living cells (mixed parenchymal and bone marrow cell fractions) 24 hr after PHx in
BMYFP and BMYFP/CXCR4/ mice.
(C) Liver regeneration of BMCXCR4fl/fl and BMCXCR4/mice, which was calculated as liver weight/body weight ratio at different days after PHx.
(D) Liver mitotic index of BMCXCR4fl/fl and BMCXCR4/ mice following H&E staining at different days after PHx.
(E) Quantification of Ki67+ liver cells by immunohistochemistry (IHC) in BMCXCR4fl/fl and BMCXCR4/ mice at different days after PHx.
(F) Scheme indicating, by red arrows, the variations of parameters fitting impaired mice data (i.e., BMCXCR4/, toxin-treated, and AMD3100) versus values for
respective control mice.
(G) 30-day simulated regeneration dynamics for BMCXCR4fl/fl and BMCXCR4/ mice.
(H) Predicted BMCXCR4/ regeneration and proliferation dynamics (solid lines) upon complete ablation of BMCs compared to the original fitting (dotted lines) and
experimental data (dots, normalized data as in Figures S2F and S2G ± SEM).
(I) Prediction of regeneration dynamics (solid lines) when BMC recruitment is stopped after 12 hr in BMCXCR4fl/fl mice against original fitting (dotted lines) and
experimental data (dots, normalized data as in Figures S2F and S2G ± SEM). Data are represented as mean ± SEM (n = 4, B and E; n = 5, D; n = 7, C). p > 0.1; *p <
0.05; **p < 0.01; ***p < 0.0001.
See also Figure S2 and Table S1.
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in BMCXCR4/ mice (Figures 2D, 2E, S2B, and S2C). Reduction
of proliferation was confirmed by fluorescence-activated cell
sorting (FACS) analysis, although it was recovered at late time
points after the surgery, likely representing a compensatory
effect through late liver parenchymal cell replication (Figures
S2D and S2E).
Model fitting confirmed the crucial role for BMCs in triggering
the proliferation and, consequently, the regeneration processes.
When reproducing regeneration and proliferation dynamics in
BMCXCR4/mice (Figures S2F and S2G), kQ (the parameter gov-
erning the propensity of cells to become primed to proliferate)
was decreased, whereas kreq and kR (the parameters describing
the return to the quiescent state), as well as the two delays (t and
q), were increased as compared to their values in the control con-
ditions (Figure 2F; Table S1). Hence, by removing BMCs from the
system, the transition of cells into a proliferative state is delayed
and less effective, the transition from the primed to the repli-
cating state is also delayed, and the sensitivity to requiescence
signals is increased. Importantly, after simulating the model for
a longer time (30 days), incomplete regeneration was observed
in BMCXCR4/ mice (Figure 2G).
Given that a small fraction of BMC population persists in
BMCXCR4/ mice (Figure 2B), the mathematical model was
used to predict regeneration dynamics in the case of more se-
vere reduction of BMCs. We found that the strength and timing
of regeneration were further impaired compared to the actual
experimental observations (Figure 2H).
Finally, we used the model to predict liver regeneration dy-
namics upon perturbation of BMC migration. Experimentally, it
was not possible to assess for how long BMCs were recruited
during the whole regeneration process. Thus, we ran simula-
tions, stopping BMC recruitment 12 hr after resection. This re-
sulted in a considerably impaired regeneration profile (Figure 2I),
thereby suggesting that BMC recruitment should take place for
at least 12 hr after surgery.
Upon Hepatectomy, Recruited BM Cells Fuse with
Hepatocytes and the Hybrids Start to Proliferate Soon
after Resection
Cell fusion is a well-known developmental process and an
essential mechanism of regeneration after an injury (Johansson
et al., 2008; Lluis and Cosma, 2010; Sanges et al., 2013, 2016;
Sullivan and Eggan, 2006; Altarche-Xifro et al., 2016). We there-
fore aimed to investigate whether mobilized BMCs could fuse
with liver cells and promote regeneration after hepatectomy.
We subjected 70% liver resection to a group of chimeric mice
carrying the R26Y transgene, in which the BM was replaced
with a double transgenic CAG-RFP/VAV-CRE BM from donor
mice (R26Y-BMRFP/CRE) (Figure 3A). Vav-Cre is expressed only
in the BM of transgenic mice (Stadtfeld and Graf, 2005); further-
more, we excluded its expression in liver cells. We found a
limited number of positive cells in sections, which likely corre-
sponded to liver resident hematopoietic cells (Figure S3A). Hep-
atectomy was performed 6 weeks after BM repopulation when
peripheral blood and bone marrow chimerisms were around
30% and 42%, respectively (Figure S3B). Up to 3 days after
resection, we found that 10%–15% of recruited RFP+ cells in
the liver were also YFP+, indicating fusion events. This percent-
age increased to50% from 7 days up to 3 weeks after surgery,
whereas recruited RFP+ cells decreased (Figures 3B, left plot,
3C, and S3C), suggesting an increase of hybrids and a decrease
of BMCs in time in the resected liver. Importantly, we excluded
major cell fusion events between BMCs and non-parenchymal
liver cells (Figures 3B, right plot, and S3D). As the control exper-
iment, to exclude a possible leakiness of the R26Y transgene and
therefore expression of YFP independently of Cre-mediated
STOP codon excision, we transplanted R26Ymice with a BMRFP
(not expressing Cre). After hepatectomy, we observed neither
YFP+/RFP+ nor YFP+/RFP cells in R26Y-BMRFP chimeric
mice (Figure S3C). Furthermore, we also excluded formation of
hybrids in the BM and peripheral blood of R26Y-BMRFP/CRE
(Figure S3B).
The increase of the hybrids at different days after surgery was
also evident by counting the number of YFP+ cells for each sec-
tion at different days after resection (Figure 3D). These results
were also confirmed by immunohistochemistry on sections
(Figure 3E). Of note, we found several YFP+ binucleated cells
(arrows in Figure 3D).
The majority of the hybrids (YFP+/RFP+ population) were
positive for markers of HSPCs (c-kit+/sca-1+) 1 day after hepa-
tectomy (Figures 3F and S3E) and for the hepatocyte markers
Albumin, hepatocyte nuclear factor 1 (Hnf1), and hepatocyte
Figure 3. BM-Recruited Cells Fuse with Parenchymal Cells after 70% PHx and the Hybrids Proliferate Soon After
(A) Experimental scheme: cell fusion was analyzed at different days after PHx in chimeric R26Y-BMRFP/CRE mice. Expression of the YFP occurs in the hybrids
formed between BMRFP/CRE and liver cellsR26Y after excision of the floxed stop codon by CRE. Hybrids will also be RFP+.
(B) Percentage of YFP+ hybrids (PC-derived hybrids, left plot; NPC-derived hybrids, right plot), with respect to pre-gated RFP+ recruited BMCs at different days
after PHx.
(C) Percentage of recruited RFP+BMCs, whichwas calculated with respect to living cells (mixed parenchymal and bonemarrow cell fractions) 1, 3, 7, and 21 days
after surgery.
(D) Quantification of the YFP+ hybrids following immunofluorescence staining at different days after PHx in R26Y-BMRFP/CRE mice. Inset: representative images;
arrows indicate binucleated cells.
(E) Representative IHC pictures of the YFP signal in sections of chimeric R26Y-BMRFP/CRE mice at different days after PHx.
(F) Percentage of c-kit+/sca-1+ cells, with respect to the total number of YFP+/RFP+ hybrids. Inset: representative FACS profile.
(G) Percentage of FACS-sorted hybrids (RFP+/YFP+) expressing the hepatocyte-specific marker HNF4a 1 day and 21 days after PHx. Inset: representative FACS
profiles.
(H) HNF4a and c-Kit immunofluorescence on hybrids (RFP+/YFP+) sorted 24 hr after PHx in R26Y-BMRFP/CRE.
(I) Percentage of Ki67+ hybrids (YFP+/RFP+) and BMCs (RFP+/YFP) 24 hr after PHx in R26Y-BMRFP/CRE mice. Data are represented as mean ± SEM (n = 3,
B [right plot], F, G, and I; n = 4, B [left plot] and C; n = 6, D). p > 0.1, *p < 0.05; **p < 0.01; ***p < 0.0001. Scale bar, 30 mm (D and E), 20 mm (H).
See also Figure S3.
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nuclear factor 4 alpha (HNF4a) from 1 day up to 21 days after sur-
gery, indicating fusion of HSPCs with hepatocytes (Figures 3G
and S3F). We confirmed these results by performing HNF4a
and c-kit immunostaining on YFP+/RFP+ hybrids sorted from
the livers of R26Y-BMRFP/CRE 24 hrs after surgery.We found cells
that were positive for both HNF4a and c-Kit expression (Fig-
ure 3H). Furthermore, 24 hr after surgery, the hybrids expressed
the cycling cell marker Ki67 and were polyploid (Figures 3I, S3G,
and S3H). In contrast, the unfused BMCs (RFP+/YFP) and
parenchymal liver cells (PCs) did not express Ki67 at this time
point (Figures 3I, S1C, and S3G).
In order to further prove whether the hepatocytes were BMC
fusion partners, we used the hepatocyte-specific Albumin-CRE
chimeric mice (Postic et al., 1999) carrying the R26Y bone
marrow (AlbCRE-BMR26Y) (Figure 4A). The hybrids largely
increased at different days after surgery (Figures 4B–4D), indi-
cating fusion of BMCs with hepatocytes.
Finally, we observed that lineage-depleted bone marrow
cells that are enriched for HSPCs could also fuse in vitro
with PCs purified after liver hepatectomy, resulting in hybrids,
which expressed HNF4a (Figures S4A and S4B). In con-
trast, lineage-positive cells did not fuse efficiently in vitro
and neither did their fusion capability increase after hepatec-
tomy (Figure S4A).
Overall, these results show that HSPCs can fuse with hepato-
cytes after liver resection and the hybrids have already entered
the cell cycle 24 hr after the surgery, at a time when hepatocytes
are still in the G0 resting phase of the cell cycle.
Because we showed that BMC migration in the liver of
BMCXCR4/ animals after hepatectomy is impaired, we then
aimed to investigate whether this block of BMC recruitment
affects hybrid formation. Thus, we injected the CXCR4 antago-
nist AMD3100 (De Clercq, 2009) into a group of chimeric
R26Y-BMRFP/CRE mice, which received 70% liver resection and
were analyzed from 24 hr to 7 days after the surgery (Figure 4E).
In the group of AMD3100-treatedmice, migration of RFP+ BMCs
(Figure 4F) and fusion of the recruited BMCs with the hepato-
cytes (YFP+ over RFP+ cells) were largely reduced after the
hepatectomy (Figures 4G and S4C). Interestingly, regeneration
was largely impaired because liver mass corrected on body
weight did not reach the level observed in the untreated mice
(Figure 1B). Fitting themathematical model on AMD3100-treated
versus control mice, regeneration data confirmed impaired
transition into the proliferative and replicating states, as in the
comparison between BMCXCR4/ and BMCXCR4fl/fl mice dis-
cussed above (Figure S4D; Table S1).
Of note, due to the lack of BMC recruitment in BMYFP/CXCR4/
mice and the reduced fusion after CXCR4 inhibition by
AMD3100, polyploidy was accordingly impaired in BMCXCR4/
mice (Figure S4E), indicating the major contribution of BMC
recruitment and bone-marrow-derived hybrids to liver regenera-
tion after hepatectomy.
Liver Regeneration Is Impaired upon Selective Ablation
of Hybrids and the Mathematical Model Correctly
Predicts this Phenotype
To definitively prove that the hybrids play an essential role to
induce liver regeneration, we used a mouse model that allows
ablation of the hybrids in the liver after surgery. We obtained
chimeric mice carrying the Rosa26-LoxP-STOP-LoxP-DTR
(R26-diphtheria toxin receptor) transgene, in whom the BM was
replaced with the CAG-RFP/VAV-CRE BM from donor mice
(R26DTR-BMRFP/CRE) (Buch et al., 2005). Upon 70% liver resec-
tion, BM-derived hybrids expressed both RFP and DTR, making
themsensitive to diphtheria toxin injection; thus, theywere selec-
tively ablated (Figure 5A). We found a substantial, although not
complete, ablation of the hybrids (DTR+ over RFP+ cells) in the
liver at the different days after surgery, which, as expected,
paralleled the reduction of RFP+ liver cells (Figures 4B and 4C).
Leakiness of the R26DTR promoter was excluded because
neither DTR+/RFP+ nor DTR+/RFP cells were found in
R26DTR-BMRFP mice (not expressing Cre) (Figure S5A). Impor-
tantly, we noticed a significant impairment of liver regeneration
in the group of toxin-treated mice (Figure 5D). Accordingly, we
found a severe reduction of the cell mitotic index, Ki67+ cell num-
ber, and polyploidy in toxin-treated mice (Figures 5E, 5F, and
S5B–S5F). As control, we excluded a possible toxic effect due
to the toxin injection. This was tested in R26DTR mice and in
R26DTR-BMRFPmice, which both showed efficient liver regener-
ation after hepatectomy and toxin injection (Figure S5G). Further-
more, proliferation in R26DTR-BMRFP mice after resection and
toxin injection was in the normal expected range (Figure S5H).
Finally, we also generated chimeric AlbCre-BMR26DTR and
analyzed liver regeneration 7 days after surgery in vehicle and
toxin-injected mice. Regeneration was severely impaired when
hepatocyte-derived hybrids were selectively ablated (Figure 5G).
Figure 4. BMCs Fuse with Hepatocytes and a Block of BM Recruitment Significantly Affects Hybrid Formation
(A) Experimental scheme: cell fusionwas analyzed by FACS, immunofluorescence (IF), and IHC after hepatectomy in chimeric AlbCRE-BMR26Ymice. Expression of
the YFP occurs in the hybrids formed between BMR26Y and hepatocytesAlb/CRE after excision of the floxed stop codon by CRE.
(B) Quantification of the YFP+ hybrids following immunofluorescence staining at different days after PHx in AlbCRE-BMR26Ymice. Inset: representative
images.
(C) Percentage of YFP+ hybrids, which was calculated with respect to living cells (mixed parenchymal and bone marrow cell fractions) 24 hr after surgery.
(D) Representative IHC pictures of the YFP signal in sections of chimeric AlbCRE-BMR26Y mice at different days after PHx.
(E) Experimental scheme: cell fusion and liver mass regeneration was analyzed at different days after hepatectomy in chimeric R26Y-BMRFP/CRE mice upon
CXCR4 inhibition by the antagonist AMD3100.
(F) Percentage of recruited RFP+ BMCs over living cells (mixed parenchymal and bone marrow cell fractions), which was measured 1, 3, and 7 days after surgery
in the presence or without the presence of the CXCR4 antagonist AMD3100.
(G) Percentage of YFP+ hybrids, with respect to pre-gated RFP+ recruited BMCs at different days after PHx in the presence or without the presence of the
CXCR4 antagonist AMD3100. Data are represented asmean ±SEM (n = 3, F andG; n = 4, C; n = 6, B). p > 0.1; *p < 0.05; **p < 0.01; ***p < 0.0001. Scale bar, 30 mm
(B and D).
See also Figure S4.
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Next, we fitted liver regeneration dynamics upon selec-
tive hybrid elimination. The fitted model confirmed major cell
proliferation defects (Figure 6A) and liver regeneration impair-
ment (Figure 6B). Identified parameters (Table S1) indicate de-
layed and less efficient transitions of the cells both into the pro-
liferative and replicating states (Figure 2F) as a consequence of
the increased sensitivity to requiescence signals upon hybrid
ablation. Moreover, no significant regeneration was observed
in simulations of mice treated with toxin for up to 30 days
(Figure 6C).
Of note, hybrids are included implicitly in themodel rather than
being modeled directly (Figures 1A and S1A). To confirm our
fitting results, we additionally derived an extended model, which
explicitly accounts for the contribution of hybrids formed by
BMCs and hepatocytes (Figure S6A; see Supplemental Experi-
mental Procedures for model derivation). Fitting the extended
model on vehicle and toxin data (Figures 6D and 6E) confirmed
the results obtained with the original model fitted on the same
data-sets, i.e., alterations in the same parameters (Figure 2F; Ta-
ble S2). Similar results were obtained with fitting the extended
model on BMCXCR4fl/fl and BMCXCR4/ data described above
(Figures 6F and 6G; Table S2).
Recently, the existing formalism in Furchtgott et al. (2009) has
been extended to include hypertrophy (Cook et al., 2015). Of
note, the authors could reproduce experimental regeneration
dynamics in a mouse (data from Shu et al., 2009), but failed in
matching proliferation dynamics. This suggests that the addition
of hypertrophy alone is insufficient to fully recapitulate mouse
liver regeneration upon hepatectomy. We investigated whether
taking hypertrophy into account would change our modeling re-
sults. An extended model that also accounts for hypertrophy, in
addition to delays and BMC recruitment (Figure S6B; see Sup-
plemental Experimental Procedures for model derivation), again
confirmed the changes in parameters shown in Figure 2F when
fitting BMCXCR4fl/fl BMCXCR4/ data (Figures 6H and 6I; Table
S3) while improving the quality of fitting presented previously
(Cook et al., 2015).
In conclusion, it is possible to model hypertrophy or hy-
brids explicitly without affecting the main fitting results. Abla-
tion of BMC-derived hybrids impairs proliferation of liver cells
and, consequently, severely harms tissue regeneration after
hepatectomy.
Mathematical Model Correctly Predicted Regeneration
Dynamics and Proliferation upon 30% PHx
Finally, we carried out experiments in which liver resection was
applied for 30% of the mass of BMCXCR4fl/fl and BMCXCR4/ and
of toxin-treated or untreated R26DTR-BMRFP/CRE mice. Data
from the group of untreated R26DTR-BMRFP/CRE mice were
used to fit 30% hepatectomy (Figure 7A), and the model correctly
predicted the regeneration dynamics of BMCXCR4fl/fl mice upon
30% resection, matching experimental data (Figure 7B).
Interestingly, model simulations predicted the absence of pro-
liferation and the synchronous dynamics of BMC recruitment
and regeneration (Figure 7A). We validated these predictions.
Indeed, also in agreement with previously published evidence
(Mitchell et al., 2005), the proliferation of hepatocytes was not
seen (Figures 7C and 7D). Liver regeneration normally occurred
in BMCXCR4fl/fl and vehicle mice, whereas a full regeneration
block was found in BMCXCR4/ and toxin-sensitive mice (Fig-
ures 7E and 7F). The latter groups also displayed a severe hybrid
loss (Figure 7G). The model, however, could not reproduce the
30% hepatectomy in impaired mice because the removal of hy-
brids and BMC recruitment, in both the original and the extended
models, result in impairment of the parameter values relative to
proliferation, which is absent in these experiments.
DISCUSSION
In this study, we have demonstrated the essential role of BMCs
for liver regeneration in mice. We found that recruitment of
HSPCs in the liver, their fusion with hepatocytes, and subse-
quent proliferation of the hybrids before that of the hepatocytes
is essential for regeneration after hepatectomy.
Previous studies have indicated the importance of the prolifer-
ation of hepatocytes for liver regeneration (Duncan et al., 2009;
Fausto et al., 2006; Michalopoulos, 2007). Alternatively, when
hepatocyte replication is blocked, differentiation of ductal liver
progenitor cells (oval cells) can play a crucial function (Itoh
and Miyajima, 2014). Here, we introduced an additional layer of
complexity to the picture, having identified the essential role of
BM-derived hybrids in the regenerative process. Although we
clearly showed that ablation of BM-derived hybrids significantly
affects liver regeneration, it is still possible that ablation of an
equivalent number of liver cells may affect the regeneration.
Figure 5. Selective Ablation of In Vivo Formed Hybrids Reduces Cell Proliferation and Impairs Liver Regeneration
(A) Experimental scheme: cell fusion and liver mass regeneration was analyzed at different days after PHx in chimeric R26DTR-BMRFP/CREmice. Expression of the
diphtheria toxin receptor (DTR) occurs in the hybrids formed between BMRFP/CRE and liver cellsR26DTR after excision of the floxed stop codon by CRE. Hybrids will
be RFP+/DTR+ and therefore sensitive to diphtheria toxin injection.
(B) Percentage of DTR+ hybrids, with respect to RFP+ recruited BMCs at different days after PHx.
(C) Percentage of recruited RFP+ BMCs over living cells (mixed parenchymal and bone marrow cell fractions), which was measured 1, 3, and 7 days after 70%
PHx of R26DTR-BMRFP/CRE mice injected or not injected with diphtheria toxin.
(D) Liver regeneration of R26DTR-BMRFP/CRE mice treated or not treated with diphtheria toxin, which was calculated as liver weight/body weight at different days
after PHx.
(E) Liver mitotic index of R26DTR-BMRFP/CRE mice treated or not treated with diphtheria toxin following H&E staining at different days after PHx.
(F) Quantification of Ki67+ liver cells by IHC in mice injected or not treated with diphtheria toxin at different days after PHx.
(G) Liver regeneration of R26DTR-BMAlb/CRE mice treated or not treated with diphtheria toxin, which was calculated as liver weight/body weight ratio 7 days after
70% PHx.
Circles indicate toxin- and vehicle- treated mice. Data are represented as mean ± SEM (n = 3, B and C; n = 4, E, F, and G; n = 5, D). p > 0.1; *p < 0.05; **p < 0.01;
***p < 0.0001.
See also Figure S5.
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This could be tested in the future by generating mice carrying
tunable DTR, whichwill allow ablation of hepatocytes in amosaic
fashion.
We showed that regeneration is blocked when CXCL12-
CXCR4 is impaired in the BMCs, which thereby cannot migrate
in the resected liver and fuse with the hepatocytes upon hepa-
tectomy. On the other hand, we cannot exclude that a minimal
fraction of resident hybrids formed before the hepatectomy
could contribute to the regeneration of the liver. However,
this appears to be independent of a possible function of the
CXCL12-CXCR4 axis. The CXCL12-CXCR4 axis maintains he-
matopoietic stem cell quiescence (Nie et al., 2008), and it has
been reported to increase proliferation of only hepatic oval cells
(Hatch et al., 2002) or hepatic stem and cancer cells (Ghanem
et al., 2014). Importantly, in our experimental system, the dele-
tion of the CXCL12-CXCR4 axis was restricted to the BMCs,
leaving the hepatic compartment and its possible proliferation
unaffected.
Besides, with hepatocytes, BMCs can fuse with a variety of
somatic cells in vivo, such as gut cells, muscle cells, and neurons
(Lluis and Cosma, 2010). After BM-derived cell transplantation in
damaged organs, the in-vivo-formed hybrids can regenerate the
tissues, thereby providing a certain degree of functional recovery
(Doyonnas et al., 2004; Johansson et al., 2008; Sanges et al.,
2013, 2016; Altarche-Xifro et al., 2016). These observations
indicate the importance of the hybrids in different regenerating
tissue contexts.
The mammalian liver is highly polyploid. The ploidy increases
with age, and it has been largely attributed to failed cytokinesis
(Duncan and Soto-Gutierrez, 2013; Margall-Ducos et al., 2007).
Polyploid hepatocytes are highly proliferative (Sigal et al.,
1999; Weglarz et al., 2000) and can repopulate the host liver after
transplantation in mice undergoing liver failure (Duncan et al.,
2010). During regeneration, proliferating polyploid hepatocytes
can also undergo multipolar mitosis and reduce their ploidy
(Duncan et al., 2010). We observed binucleated and mononucle-
ated cells, suggesting that heterokaryonsmight convert into syn-
karyons or reduce their ploidy during the regeneration process
after the hepatectomy. Overall, liver function is fully maintained
by polyploid cells and even by aneuploid hepatocytes (Duncan
and Soto-Gutierrez, 2013).
In addition to failed cytokinesis, polyploid cells are formed by
fusion with BMCs, as previously reported (Vassilopoulos et al.,
2003; Wang et al., 2003) and our data here show. In the fumary-
lacetoacetate hydrolase knockout mice (Fah/), hybrids formed
upon fusion of BMCs with hepatocytes survived under selection
pressure, i.e., upon withdrawal of the drug 2-(2-nitro-4-trifluoro-
methylbenzyol)-1,3-cyclohexanedione (NTBC), which prevents
liver disease in Fah/ mice (Vassilopoulos et al., 2003; Wang
et al., 2003). Here, we observed formation of the hybrids without
drug selection in a physiological model of liver regeneration,
and discovered that they have a fundamental role for organ
regeneration.
The function of this high ploidy was still not fully understood.
Here, we demonstrated that proliferation of the hybrids before
that of the hepatocytes is essential for liver mass regeneration
after hepatectomy, clearly attributing a functional role to the
polyploid cells. In addition, mathematical modeling showed
that hybrid removal strongly impairs the regeneration process,
delaying the transition of liver cells into a proliferative state and
increasing the sensitivity to requiescence signals. Whether the
newly formed hybrids directly trigger proliferation of the unfused
hepatocytes, which enter in the cell cycle with a delay of 24 hr
with respect to the hybrids, still needs to be defined.
We refined an existing mathematical model to account for the
role of BMCs and hybrids in triggering regeneration, predicting
regeneration efficiency in experimentally non-observable condi-
tions. Our model explicitly considers BMCs while implicitly ac-
counting for hybrids because BMCs are directly summed to
the quiescent state (Supplemental Experimental Procedures).
We opted for this approach because of limited experimental ac-
cess to isolated hybrid dynamics in some of the mice used in this
study (i.e., BMCXCR4fl/fl and BMCXCR4/ animals). Nevertheless,
extended formalisms, which include hybrids or that take into ac-
count hypertrophy as additional variables, confirmed results
about the effect of impairment of BMC recruitment and hybrids
on the system dynamics, confirming the power of our simplified
approach.
Alternative mathematical formalisms describing liver physi-
ology (reviewed in Holzh€utter et al., 2012) account for multiscale
levels of organization, extra-hepatic contribution (Diaz Ochoa
et al., 2013), and the different nature of cells participating in pa-
thology or regeneration (Hoehme et al., 2010). Our mathematical
formalism has the potential to be extended to include spatial
information and a more detailed description of the molecular
processes involved in BM and hybrid-mediated regeneration;
however, this would require the specification of additional pa-
rameters, which are at present not directly accessible experi-
mentally. Although simple, our model has been parametrized
by all available data and constitutes a first step in refining our
quantitative understanding of regeneration and proliferation dy-
namics upon partial hepatectomy.
In humans, liver regeneration occurs after ischemia, toxic
damage by alcohol, viral infection, or immune-mediated injury
Figure 6. Modeling the Contribution of BMC Recruitment and Cell Fusion to Cell Proliferation and Liver Regeneration Dynamics
(A and B) Simulations of the fitted model for proliferation (A) and liver mass (B) for R26DTR-BMRFP/CRE in toxin and vehicle-treated mice using normalized data
from Figures 5D and S5D.
(C) 30-day simulated regeneration dynamics for R26DTR-BMRFP/CRE in toxin and vehicle-treated mice.
(D and E) Simulations of the fitted extended model (hybrids) for proliferation (D) and liver mass (E) for R26DTR-BMRFP/CRE toxin and vehicle-treated mice using
normalized data from Figures 5D and S5D.
(F and G) Simulations of the fitted extended model (hybrids) for proliferation (F) and liver mass (G) for BMCXCR4fl/fl and BMCXCR4/ mice using normalized data
from Figures 2C and S2D.
(H and I) Simulations of the fitted extended model (hypertrophy) for liver mass (H) and proliferation (I) for BMCXCR4fl/fl and BMCXCR4/mice using normalized data
from Figures 2C and S2D. See also Figure S6 and Tables S1, S2, and S3.
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Figure 7. Modeling Simulations and Experimental Validations for the 30% PHx Model
(A) Fitted model simulations (solid lines) and experimental data (dots, normalized data from Figure 7F ± SEM) for regeneration, BMC recruitment, and proliferation
dynamics upon 30% PHx in vehicle-treated mice.
(B) Prediction of regeneration dynamics (solid lines) for 30% PHx in BMCXCR4fl/fl mice against experimental data (dots, normalized data from Figure 7E ± SEM).
(C) Percentage of Ki67+ cells over parenchymal cells, which was measured by FACS 1, 2, 3, and 4 days after 30% PHx in BMCXCR4fl/fl and BMCXCR4.
(D) Percentage of Ki67+ cells over parenchymal cells, which was measured by FACS 1, 2, 3, and 4 days after 30% PHx in R26DTR-BMRFP/CRE chimeric mice
treated or not treated with diphtheria toxin.
(E) Liver regeneration of BMCXCR4fl/fl and BMCXCR4/ mice, which was calculated as liver weight/body weight ratio 1, 2, 3, and 4 days after 30% PHx.
(F) Liver regeneration of R26DTR-BMRFP/CRE chimeric mice treated or not treated with diphtheria toxin, which was calculated as liver weight/body weight ratio 1,
2, 3, and 4 days after 30% PHx.
(G) Percentage of in vivo formed hybrids between recruited BMRFP/CRE and parenchymal liver cellsR26DTR 1, 2, 3, and 4 days after 30% PHx in control mice and
mice injected with diphtheria toxin. The percentage of hybrids (DTR+/RFP+) was calculated with respect to living cells (mixed parenchymal and bone marrow cell
fractions). Data are represented as mean ± SEM (n = 3, C, D, F, and G; n = 5, E). p > 0.1, *p < 0.05; **p < 0.01; ***p < 0.0001.
See also Table S1.
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(Koniaris et al., 2003). The liver regeneration mechanism should
be fully dissected to elucidate how the liver responds to these
types of insults and because partial resection is a current chirur-
gical practice for living liver donors. In contrast to rodents, the
human liver regenerates more slowly, although efficiently for its
function (Taub, 2004). Thus, the length of cell proliferation can
diversify the mechanisms of liver regeneration in mammals.
The early proliferation of BM-derived hybrids we found here
can be potentially exploited, not only to improve regeneration af-
ter hepatectomy, but also for future attempts toward regenera-
tive therapy in patients affected by liver failure.
EXPERIMENTAL PROCEDURES
Mice
All mice used in this study, R26Y [B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J]
(Srinivas et al., 2001), BMCXCR4fl/fl [B6.129P2-Cxcr4tm2Yzo/J] (Ephrussi and
St Johnston, 2004), CAG-RFP [B6.Cg-Tg(CAG-mRFP1)1F1 Hadj/J] (Gregor
et al., 2005), R26DTR [C57BL/6-Gt(ROSA) 26Sortm1(HBEGF)Awai/J] (Buch
et al., 2005), Vav-Cre (Stadtfeld and Graf, 2005), and Alb-CRE [B6.Cg-
Tg(Alb-Cre)21Mgn/J] (Postic et al., 1999), were kept in a barrier and SPF
animal facility in accordance with the CEEA (Ethical Committee for Animal
Experimentation) of the Government of Catalonia. Males and females between
9 and 12 weeks were used for the experiments.
Flow Cytometry and Cell Sorting
Mice were euthanized with CO2 and perfused with PBS until the liver lobes
drained off the blood and appeared pale. Liver samples were collected, and
cells were purified by a double disaggregation step, as described in the Sup-
plemental Experimental Procedures. Purified cells were pelleted and resus-
pended in PBS with 2% FCSwith DAPI and analyzed using a BD LSR Fortessa
(see Supplemental Experimental Procedures for more details). For cell sorting
of in vitro and in vivo formed hybrids, samples were prepared as reported
above and sorted using a BD FACS aria II.
Statistical Analysis
The percentage of recruited BMCs, hybrids (in vivo and in vitro formed), and
cycling cells (Ki67+) was measured by FACS and calculated using the BD
FACSDiva software. For quantification of YFP+ hybrids (three random fields
for each mouse) and Ki67+ hepatocytes (five random fields for each mouse)
in liver sections, we used image processing tools in ImageJ software (US
NIH; http://rsb.info.nih.gov/ij). Data are reported asmean ±SEM, and the num-
ber of replicates is specified in the figure legends. Differences were examined
using two-tailed unpaired Student’s t tests, and p < 0.05 was considered
significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.12.008.
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